Display options
Share it on

Onco Targets Ther. 2021 Nov 27;14:5335-5344. doi: 10.2147/OTT.S340435. eCollection 2021.

The Controversial Role of Polyploidy in Hepatocellular Carcinoma.

OncoTargets and therapy

Nan Wang, Fengjie Hao, Yan Shi, Junqing Wang

Affiliations

  1. Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
  2. Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

PMID: 34866913 PMCID: PMC8636953 DOI: 10.2147/OTT.S340435

Abstract

Polyploidy, a physiological phenomenon in which cells contain more than two sets of homologous chromosomes, commonly exists in plants, fish, and amphibians but is rare in mammals. In humans, polyploid cells are detected commonly in specific organs or tissues including the heart, marrow, and liver. As the largest solid organ in the body, the liver is responsible for a myriad of functions, most of which are closely related to polyploid hepatocytes. It has been confirmed that polyploid hepatocytes are related to liver regeneration, homeostasis, terminal differentiation, and aging. Polyploid hepatocytes accumulate during the aging process as well as in chronically injured livers. The relationship between polyploid hepatocytes and hepatocellular carcinoma, the endpoint of most chronic liver diseases, is not yet fully understood. Recently, accumulated evidence has revealed that polyploid involves in the process of tumorigenesis and development. The study of the correlation and relationship between polyploidy hepatocytes and the development of hepatocellular carcinoma can potentially promote the prevention, early diagnosis, and treatment of hepatocellular carcinoma. In this review, we conclude the potential mechanisms of polyploid hepatocytes formation, focusing on the specific biological significance of polyploid hepatocytes. In addition, we examine recent discoveries that have begun to clarify the relevance between polyploid hepatocytes and hepatocellular carcinoma and discuss recent excellent findings that reveal the role of polyploid hepatocytes as resisters of hepatocellular carcinoma or as promoters of hepatocarcinogenesis.

© 2021 Wang et al.

Keywords: cancer; cell cycle; hepatocyte; liver; polyploidy

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

  1. J Cell Biochem. 2018 Jul;119(7):6238-6248 - PubMed
  2. Cell Cycle. 2010 Feb 1;9(3):460-6 - PubMed
  3. Genes Dev. 2017 Jan 1;31(1):34-45 - PubMed
  4. Hepatology. 2013 May;57(5):2004-13 - PubMed
  5. J Clin Invest. 2009 Jul;119(7):1880-7 - PubMed
  6. J Cell Biol. 2015 May 25;209(4):485-91 - PubMed
  7. Dev Cell. 2010 Feb 16;18(2):175-89 - PubMed
  8. Dev Cell. 2018 Feb 26;44(4):447-459.e5 - PubMed
  9. Cell. 2018 Sep 20;175(1):200-211.e13 - PubMed
  10. Hepatology. 2016 Aug;64(2):599-615 - PubMed
  11. Mol Cell. 2017 Aug 3;67(3):400-410.e7 - PubMed
  12. Am J Pathol. 2014 Feb;184(2):322-31 - PubMed
  13. Nat Rev Mol Cell Biol. 2014 Mar;15(3):197-210 - PubMed
  14. Oncogene. 2004 Feb 26;23(8):1489-97 - PubMed
  15. Gastroenterology. 2012 Jan;142(1):25-8 - PubMed
  16. Nat Cell Biol. 2012 Nov;14(11):1181-91 - PubMed
  17. Nat Genet. 2018 Aug;50(8):1189-1195 - PubMed
  18. Front Physiol. 2017 Oct 31;8:862 - PubMed
  19. Cell Death Dis. 2017 May 18;8(5):e2805 - PubMed
  20. Nature. 2009 Jul 9;460(7252):278-82 - PubMed
  21. Hepatology. 2019 Mar;69(3):1242-1258 - PubMed
  22. Cancer. 1988 Apr 15;61(8):1555-62 - PubMed
  23. Science. 1989 Nov 3;246(4930):629-34 - PubMed
  24. EMBO J. 2011 Jan 19;30(2):355-63 - PubMed
  25. Clin Cancer Res. 1999 May;5(5):963-70 - PubMed
  26. Inflamm Res. 2002 Aug;51(8):416-22 - PubMed
  27. CA Cancer J Clin. 2021 May;71(3):209-249 - PubMed
  28. J Cell Sci. 2007 Oct 15;120(Pt 20):3633-9 - PubMed
  29. Gut. 2020 Feb;69(2):355-364 - PubMed
  30. Gastroenterology. 2018 Apr;154(5):1421-1434 - PubMed
  31. Dev Cell. 2020 Feb 10;52(3):335-349.e7 - PubMed
  32. Gastroenterology. 2020 May;158(6):1698-1712.e14 - PubMed
  33. Annu Rev Cell Dev Biol. 2011;27:585-610 - PubMed
  34. Cell Cycle. 2019 Jun;18(12):1302-1315 - PubMed
  35. Cancer Cell. 2012 Jun 12;21(6):765-76 - PubMed
  36. Cold Spring Harb Perspect Biol. 2015 Feb 13;7(4):a015834 - PubMed
  37. Nat Commun. 2021 Jan 28;12(1):645 - PubMed
  38. J Biol Chem. 2003 May 23;278(21):19095-101 - PubMed
  39. Nat Rev Clin Oncol. 2018 Mar;15(3):139-150 - PubMed
  40. J Clin Invest. 2015 Mar 2;125(3):981-92 - PubMed
  41. Nat Cell Biol. 2012 Nov;14(11):1192-202 - PubMed
  42. Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3826-31 - PubMed
  43. Nature. 2010 Oct 7;467(7316):707-10 - PubMed
  44. Cancers (Basel). 2021 Oct 14;13(20): - PubMed
  45. Adv Exp Med Biol. 2010;676:123-35 - PubMed
  46. EMBO Rep. 2020 Dec 3;21(12):e50893 - PubMed
  47. Curr Biol. 2012 Jul 10;22(13):1166-75 - PubMed
  48. Mol Cell. 2015 Apr 2;58(1):147-56 - PubMed
  49. Nat Rev Gastroenterol Hepatol. 2020 Jul;17(7):391-405 - PubMed
  50. Nat Commun. 2021 Mar 25;12(1):1896 - PubMed
  51. Biomed Pharmacother. 2021 Aug;140:111731 - PubMed
  52. Hepatology. 2008 Nov;48(5):1655-64 - PubMed
  53. Curr Biol. 2014 Mar 17;24(6):598-608 - PubMed
  54. Nat Commun. 2021 Jan 28;12(1):646 - PubMed
  55. Semin Cell Dev Biol. 2013 Apr;24(4):347-56 - PubMed
  56. Curr Opin Cell Biol. 2018 Jun;52:136-144 - PubMed
  57. Proc Natl Acad Sci U S A. 1967 Feb;57(2):327-34 - PubMed
  58. Development. 2018 Jul 18;145(14): - PubMed
  59. Cell Stem Cell. 2020 Jan 2;26(1):34-47.e3 - PubMed
  60. Cancer Res. 2005 Jun 1;65(11):4568-77 - PubMed

Publication Types